↗5 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$4.4MSold on the market
1Companies
Oct 6, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 202616:35 | Oct 2, 2026 | LGNDLIGAND PHARMACEUTICALS INC | CLO & Secretary | S · Sell10b5-1 | $304.07 | −5,000 | 31,854 | -14% | −$1.5M | ||
| Oct 6, 202616:35 | Oct 2, 2026 | LGNDLIGAND PHARMACEUTICALS INC | CLO & Secretary | M · Exercise10b5-1 | $52.27 | +340 | 36,854 | +1% | $18K | ||
| Sep 8, 202618:34 | Sep 3, 2026 | LGNDLIGAND PHARMACEUTICALS INC | CLO & Secretary | S · Sell10b5-1Late 5d | $286.09 | −5,000 | 36,514 | -12% | −$1.4M | ||
| Aug 4, 202618:42 | Aug 3, 2026 | LGNDLIGAND PHARMACEUTICALS INC | CLO & Secretary | S · Sell10b5-1 | $288.99 | −5,000 | 41,514 | -11% | −$1.4M | ||
| Aug 4, 202618:42 | Aug 3, 2026 | LGNDLIGAND PHARMACEUTICALS INC | CLO & Secretary | M · Exercise10b5-1 | $52.27 | +5,000 | 46,514 | +12% | $261K |